Nongshim-affiliated Newteranex acquires Namshin Pharm to enter drug distribution market
Newteranex, a subsidiary of Nongshim, acquired employees and business rights of Namshin Pharm(CEO Joon-Ho Lee) to enter the pharmaceutical distribution market.
Using the acquisition of the company as an opportunity, Newteranex expects its own drug store, Pandora, to grow a step higher, and Pando...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.